Download Booklet - Diabetes in Asia Study Group

Atract Title
the utility of Compliance electronic Devices in estimating patient Compliance in t2DM: a pilot
Study in Qatari.
Name of Author: Dr. Nadir Kheir
Co Authors : Dr. bill Greer ;Dr. adil yousif ; hajer alGeed; randa al okkah; Manal Zaidan; Dr.
Mahmoud Zirie
Introduction
so far there is no accepted “Gold standard” to objectively assess compliance with drug therapy.
strategies that use information from patients include self-reporting, pill-counting and the use of
Compliance electronic Devices (CeD). one such device is the Medication event Monitoring system,
or MeMs® (a computerized device attached with the medicine bottles given to patients). to our
knowledge, CeD had not been tested in the Gulf country region.
Objectives
to assess the usefulness of the MEMS® in assessing compliance
Methods
A sample of adult diabetic Qatari patients attending an outpatient diabetic clinic were administered
a Knowledge, attitude, and practices (Kap) questionnaire and then dispensed one of their regular
medications in a MeMs®-fitted bottle. Data contained in the MeMs® were downloaded after
the patients returned for a refill and compliance was estimated using 2 methods: pill count and
MEMS® data.
Results
Compliance with daily doses was 67% and with regimen 46%. no correlation was found between
compliance assessed by pill count and MeMs®. there were significant correlations between some
of the Kap domains. the association between Kap and compliance was generally poor.
Conclusions
While an attractive innovation, the MeMs poses many challenges. the societal characteristics of
patients are important factors in assessing compliance. the study helped uncovering problems
associated with the use of MeMs® and that could affect its usefulness and validity in assessing
compliance in this part of the world.
40